Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Accumulated Expenses (2016 - 2025)

Neuroone Medical Technologies' Accumulated Expenses history spans 12 years, with the latest figure at $706112.0 for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 399.16% year-over-year to $706112.0; the TTM value through Dec 2025 reached $706112.0, up 399.16%, while the annual FY2025 figure was $1.3 million, 9.18% up from the prior year.
  • Accumulated Expenses reached $706112.0 in Q4 2025 per NMTC's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.3 million in Q3 2025 to a low of $41646.0 in Q1 2024.
  • Average Accumulated Expenses over 5 years is $632330.0, with a median of $610090.0 recorded in 2023.
  • Peak YoY movement for Accumulated Expenses: tumbled 93.02% in 2024, then soared 1947.22% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $356374.0 in 2021, then soared by 32.75% to $473085.0 in 2022, then soared by 31.74% to $623240.0 in 2023, then plummeted by 77.3% to $141459.0 in 2024, then soared by 399.16% to $706112.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Accumulated Expenses are $706112.0 (Q4 2025), $1.3 million (Q3 2025), and $958056.0 (Q2 2025).